SEC Filing Document

Company: Jones Ventures INTL Acquisition1 Corp
Ticker: 
CIK: 2129056
Filing Type: DRS
Document Type: DRS
Date Filed: 2026-04-13
Accession Number: 0001213900-26-042636
Exchange: 
SIC Code: 6770
SIC Description: Blank Checks
URL: https://www.sec.gov/Archives/edgar/data/2129056/000121390026042636/filename1.htm

Chunk 4 of 140
Word Count: 1428
Character Count: 9165

Document Content:

symbols “JONE” and “JONER” respectively. We are an “emerging growth company” and a “smaller reporting company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 46 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings. Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. No offer or invitation, whether directly or indirectly, is being or may be made to the public in the Cayman Islands to subscribe for any of our securities. Per Unit Total

Public offering price $	10.00 $	200,000,000

Underwriting discounts and commissions (1) $	0.20 $	4,000,000

Proceeds, before expenses, to us $	9.80 $	196,000,000

(1)      Represents $0.20 per unit, equal to 2.0% of the gross proceeds of this offering, or $4,000,000 in the aggregate (regardless of whether the underwriters’ over-allotment option is exercised), payable to the underwriters upon the closing of this offering. We will also pay $300,000 to [•] for acting as a “qualified independent underwriter” in this offering. See the section of this prospectus entitled “Underwriting (Conflicts of Interest)” beginning on page 189 for a description of compensation and other items of value payable to the underwriters.

Of the proceeds we receive from this offering and the sale of the private placement units described in this prospectus, $200 million, or $230 million if the underwriters’ overallotment option is exercised in full ($10.00 per unit in either case), will be placed into a U.S.-based trust account with Continental Stock Transfer & Trust Company acting as trustee.

Because our Sponsor acquired the Class B ordinary shares at a nominal price, our public shareholders will incur immediate and substantial dilution upon the closing of this offering assuming no value is ascribed to the Share Rights included in the units. As a result, the holders of our founder shares (including certain of our directors and officers that indirectly own founder shares) could make a substantial profit after our initial business combination even if our

Table of Contents

public shareholders lose money on their investment as a result of a decrease in the post-combination value of their Class A ordinary shares. If we increase or decrease the size of the offering, we will effect a share capitalization or a share repurchase or redemption or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of the offering in such amount as to maintain the ownership of founder shares by our initial shareholders, on an as-converted basis, at 25% of our issued and outstanding ordinary shares upon the consummation of this offering (not including the Class A ordinary shares comprising part of the private placement units). Further, the Class A ordinary shares issuable in connection with the conversion of the founder shares may result in material dilution to our public shareholders due to the anti-dilution rights of our founder shares that may result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion. Further, our public shareholders may experience material dilution if the $1,500,000 in working capital loans is fully advanced by the Sponsor and the Sponsor elects to convert the working capital loans into private placement units at $10.00 per unit, resulting in the Sponsor receiving an additional 150,000 private units. If we raise additional funds through equity or convertible debt issuances, our public shareholders may also suffer significant dilution. This dilution would increase to the extent that the anti-dilution provision of the founder shares results in the issuance of Class A shares on a greater than one-to-one basis upon conversion of the founder shares at the time of our initial business combination. Additionally, securities to be issued in the private placement, as well as units that may be issued upon conversion of up to $1,500,000 of working capital loans, including the securities underlying such units, may result in a material dilution of our public shareholders’ equity interests. See the sections titled “Risk Factors — Risks Relating to our Securities — The nominal purchase price paid by our Sponsor for the founder shares will result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our Sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline”, “— We may issue additional Class A ordinary shares or preference shares to complete our initial business combination or under an employee incentive plan after completion of our initial business combination. We may also issue Class A ordinary shares upon the conversion of the founder shares at a ratio greater than one-to-one at the time of our initial business combination as a result of the anti-dilution provisions contained therein. Any such issuances would dilute the interest of our shareholders and likely present other risks”, and “Dilution.”

The following table illustrates the difference between the public offering price per unit and our net tangible book value per Class A ordinary share (“NTBV”), as adjusted to give effect to this offering and assuming the redemption of our public shares at varying levels and the exercise in full and no exercise of the over-allotment option. See the section titled “Dilution” on page 99 for more information.

As of December 31, 2025

Offering Price of $10.00 per Unit 25% of Maximum Redemptions 50% of Maximum Redemptions 75% of Maximum Redemptions Maximum Redemptions

NTBV NTBV Difference between NTBV and Offering Price NTBV Difference between NTBV and Offering Price NTBV Difference between NTBV and Offering Price NTBV Difference between NTBV and Offering Price

Assuming Full Exercise of Over-Allotment Option

Assuming No Exercise of Over-Allotment Option

Our Sponsor and members of our management team will directly or indirectly own our securities following this offering, and accordingly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. Additionally, each of our officers and directors presently has, and any of them in the future may have additional, fiduciary, contractual or other obligations or

Table of Contents

duties to one or more other entities, including to Jones and their affiliates as well as to clients or third parties serviced by Jones or other affiliates of our Sponsor or our officers or directors, pursuant to which such officer or director is or will be required to present a business combination opportunity to such entities. As a result, there may be actual or potential material conflicts of interest between our Sponsor and its affiliates on one hand, and purchasers in this offering on the other. See the sections titled “Proposed Business — Sourcing of Potential Business Combination Targets” and “Management — Conflicts of Interest” for more information.

The underwriters are offering the units for sale on a firm commitment basis. The underwriters expect to deliver the units to the purchasers on or about            , 2026.

Lead Book-Running Manager

Jones

Table of Contents

Table of Contents

Page

The Offering 16

Summary Financial Data 42

Summary of Risks 43

Risk Factors 46

Cautionary Note Regarding Forward-Looking Statements 93

Use of Proceeds 94

Dividend Policy 98

Dilution 99

Capitalization 102

Management’s Discussion and Analysis of Financial Condition and Results of Operations 103

Proposed Business 109

Effecting our Initial Business Combination 123

Management 142

Principal Shareholders 154

Certain Relationships and Related Party Transactions 157

Description of Securities 161

Taxation 180

Underwriting (Conflicts of Interest) 189

Legal Matters 198

Experts 198

Where You Can Find Additional Information 198

Index to Financial Statements F-1

We are responsible for the information contained in this prospectus. We have not, and the underwriters have not, authorized anyone to provide you with information that is different from or inconsistent with that contained in this prospectus. We are not, and the underwriters are not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus.

Trademarks